609th MEETING, LEEDS 159 and phosphatidylcholine also facilitates the secretion of very-low-density lipoproteins (Pittner el ' al., 1985).
In conditions of metabolic stress and in diabetes the liver secretes glucose, ketones and very-low-density lipoproteins. Glucose and ketones are used by the brain as a source of energy, whereas the fatty acids that are derived from the verylow-density lipoproteins, and some of the ketones, are taken up by heart and skeletal muscle for oxidation (Brindley & Lawson, 1983) . The ability of the liver to synthesize and secrete triacylglycerols in stress conditions (Brindley & Sturton, 1982) and in diabetes (Whiting et al., 1977; Murthy & Shipp, 1979; Woods et al., 1982) appears to be related to the high activities of PAP. This occurs partly because the synthesis of PAP is stimulated by glucocorticoids and that relatively low concentrations of insulin fail to antagonize this effect (Lawson et al., 1982a,b) .
The present work focuses attention 0 1 1 the role of cyclic AMP in regulating the synthesis of PAP and TAT in the liver. The latter enzyme was chosen because it is involved in the breakdown of an amino acid and the use of the carbon skeletons for gluconeogenesis. The hormonal regulation of its synthesis is fairly well documented.
Cyclic A M P increases the activity of pho!phatidate phosphohydrolase in rat hepatocytes Rat hepatocytes were incubated in monolayer culture in the presence of various combinations of a cyclic AMP analogue, 8-(4-~hlorophenylthio)adenosi:ne 3'3'-monophosphate, dexamethasone and insulin (Pittner et al., 1985) . The analogue ( 1 0 0~~) increased the activities of PAP and TAT by 2.6-and 3.4-fold respectively after 8 h. These effects were Abbreviations used: PAP, phosphatidate phosphohydrolase (EC 3.1.3.4); TAT, tyrosine aminotransferase (EC 2.6. I .5), blocked by actinomycin D, which indicates that they are probably caused by the stimulation of protein synthesis. Insulin did not reverse the effects of the analogue, but this may be a result of the relative resistance of the analogue to degradation by the phosphodiesterase.
The addition of l00nM-dexamethasone to the incubations increased the activities of PAP and TAT by approx. 3.5-fold after 8 h (Pittner et al., 1985) . As expected from previous work, the changes in the activities of PAP and T A T were blocked by actinomycin D (Jennings el al., 1981) . Insulin also completely suppressed the induction by dexamethasone of PAP activity and partially prevented that of TAT.
The increases in the activity of PAP and TAT were approximately additive when these two compounds were added together ( Fig. 1 ; Pittner et al., 1985) .
Metabolic signijcance of the results
The results indicate that the high cyclic AMP concentrations that are seen in stress and diabetes can stimulate the synthesis of PAP and augment the action of glucocorticoids in this respect. However, cyclic AMP also causes the PAP to be inactivated and displaced from the endoplasmic reticulum into the cytosol (Butterwith et al., 1984 (Butterwith et al., , 1985 . This should favour P-oxidation by decreasing the rate of fatty acid esterification when the supply of fatty acids is low (Pelech et al., 1983) . In addition, the high concentrations of cyclic AMP would inhibit acetyl-CoA carboxylase, and the low malonyl-CoA concentrations would relieve the inhibition of carnitine palmitoyltransferase (McGarry & Foster, 1980) . However, the liver has to retain a high capacity for triacylglycerol synthesis in stress and diabetes in order to protect itself against large increases in the supply of fatty acids from adipose tissue. This increased capacity exists in the form of the cytosolic pool of PAP, which can be activated and translocated to the endoplasmic reticulum as the fatty acid load increases, reversing the effects of cyclic AMP. The synthesis of triacylglycerols limits the increase in the concentrations of fatty acids and acyl-CoA esters in the liver and it regenerates the CoA. The triacylglycerols can accumulate and produce a fatty liver, or they can be secreted Vol. 13 regulating enzymes of amino acid breakdown and gluconeogenesis, thereby increasing the capacity of the liver to synthesize triacylglycerols and glucose. Insulin generally antagonizes these effects (Lawson et al., 1982a,b) . We are now able to add the effect of cyclic AMP to this list. It stimulates the synthesis of PAP on its own and it supplements the action of the glucocorticoids in a similar way to its effect on gluconeogenesis. in very-low-density lipoproteins. The lipoproteins are specifically directed to cardiac and skeletal muscle, where the activity of lipoprotein lipase is maintained by glucocorticoids rather than by insulin (Cryer, 1981) .
In stress and diabetes the liver supplies other organs with energy in the form of ketones, glucose and triacylglycerol.
Several parallels are now evident in the control of gluconeogenesis and the regulation of triacylglycerol synthesis through changes in the activity of PAP. First, vasopressin (and possibly other hormones that mobilize CaZ+) rapidly increase PAP activity and stimulate triacylglycerol synthesis and gluconeogenesis (Pollard & Brindley, 1984) . Glucocorticoids stimulate the synthesis of PAP and of the
